Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol.
Maija Liv JohansenGeetha MahendranLeslie P LawleyPublished in: Pediatric dermatology (2021)
Prolonged in-office monitoring of propranolol initiation and dose escalation (Protocol 1) may not be necessary for the setting of adequate prescreening as it does not predict immediate or future adverse events.